DESCRIBE-AD: A novel classification framework for atopic dermatitis - 19/08/22
Abstract |
Background |
Atopic dermatitis (AD) is a chronic, inflammatory skin disease associated with heterogeneous morphology, distribution, symptoms, severity, extent, longitudinal courses, quality of life burden, comorbidities, and treatment responses. This heterogeneity contributes to challenges in diagnosis, the characterization of disease activity, and therapeutic stratification.
Objective |
To develop a framework to standardize AD assessment.
Methods |
We propose a novel framework to assess AD based on a literature review and clinical experience.
Results |
DESCRIBE-AD is a framework that can effectively capture the clinical domains contributing to AD heterogeneity and includes both patient- and clinician-reported perspectives. DESCRIBE-AD includes assessments of Dermatitis morphology and phenotype, Evolution of disease, Symptom severity, Comorbid health disorders, Response to therapy, Intensity of lesions, Burden of disease, and Extent of lesions. Rather than placing the focus on any single, specific aspect of AD, DESCRIBE-AD allows for a comprehensive approach to the assessment and clinical management of AD.
Conclusions |
DESCRIBE-AD is a novel framework that can be used to better describe the heterogeneity of AD and guide treatment decisions.
Le texte complet de cet article est disponible en PDF.Key words : atopic dermatitis, burden, eczema, heterogeneity, outcome, severity
Abbreviations used : AD, BSA, HRQOL, IGA, MH, SCORAD, SD, vIGA-AD, QOL
Plan
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
Vol 87 - N° 3
P. 541-550 - septembre 2022 Retour au numéro
Article précédent
- The criteria-dependent risk of systemic lupus erythematosus developing in patients with discoid lupus erythematosus
- Warren R. Heymann
- Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society
- Félix Pham, Amélie Boespflug, Gérard Duru, Alice Phan, Nicolas Poulalhon, Laura Weiler, Masaru Tanaka, Aimilios Lallas, Dai Ogata, Anne Céline Davaine, Philippe Bahadoran, Xavier Balguerie, Grażyna Kamińska-Winciorek, Isabelle Tromme, Osvaldo Correia, Moon-Bum Kim, Ashfaq A. Marghoob, Pascale Guitera, Mariame Meziane, Juliette Miquel, Je-Ho Mun, Giuseppe Argenziano, Didier Bessis, Johnny Bourke, Zeljko Mijuskovic, Christine Chiaverini, Cloé Corven-Benoit, Catherine Droitcourt, François Skowron, Myriam Marque, Iris Zalaudek, Cliff Rosendahl, David Moreno-Ramirez, Pierre Vabres, Holger Haenssle, Josep Malvehy, Susana Puig, Caroline Robert, Thomas R. Schopf, Alon Scope, Stéphane Dalle, Luc Thomas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?